Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Victorian Comprehensive Cancer Centre
lungcanc
Alectinib and ALK-Positive Non-Small Cell Lung Cancer – Q&A with Alice...
lungcanc
What Have We Learned from the National Lung Screening Trial?
lungcanc
Small Cell Lung Cancer: The Next Challenge
lungcanc
2016 ASCO Annual Meeting
lungcanc
PD-L1 IHC Blueprint Project” Presented at the AACR Annual Meeting 2016
lungcanc
A Practical Approach to the Evaluation of Pulmonary Nodules
lungcanc
Update on Low-Dose CT Lung Cancer Screening Implementation in the United...
lungcanc
IASLC and APLCC Present 7th IASLC Asia Pacific Lung Cancer Conference
lungcanc
From the Editor – Corey J. Langer
lungcanc
1
...
47
48
49
...
53
Page 48 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
